BIOASSAY OF PROCOAGULANT ALBUMIN IN HUMAN PLASMA

被引:5
|
作者
GROSSET, A
LIU, LH
PARKER, CJ
RODGERS, GM
机构
[1] UNIV UTAH, HLTH SCI CTR, DIV HEMATOL ONCOL, SALT LAKE CITY, UT 84132 USA
[2] UNIV UTAH, HLTH SCI CTR, DEPT MED, SALT LAKE CITY, UT 84132 USA
[3] UNIV UTAH, HLTH SCI CTR, DEPT PATHOL, SALT LAKE CITY, UT 84132 USA
[4] VET AFFAIRS MED CTR, SALT LAKE CITY, UT 84148 USA
基金
美国国家卫生研究院;
关键词
TISSUE FACTOR; ENDOTHELIUM; THROMBOSIS; BIOASSAY;
D O I
10.1016/0049-3848(94)90229-1
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Procoagulant albumin (P-Al) is present in normal human plasma and increases monocyte and endothelial cell expression of tissue factor activity. To develop a bioassay for P-Al, we partially purified plasma from healthy volunteers and several patient groups using BaCl2 and (NH4)(2)SO4 precipitation. The samples were assayed for tissue factor (TF) inducing activity, expressed as a percentage increase compared to a serum-free media control. Over six months, the assay was reproducible in stored samples and in serial samples from normal volunteers. The plasma P-Al activities of 35 volunteers averaged 141 +/- 8.2% (SEM). There was no diurnal variation. There was no difference in the P-Al activity after a 12 hour fast and 2 hours after a large meal in 4 healthy volunteers. There was no increase in activity (r = 0.16) with the subject's age. The average activity from 16 poorly-controlled diabetics was 131 +/- 11% (SEM). No alteration in activity was seen with samples from patients with uremia, liver dysfunction, hemophilia, thrombotic events, or adenocarcinoma. These results indicate that P-Al activity can be bioassayed in individual patient samples; however, pathologic states associated with abnormal P-Al-induced tissue factor activity presently remain unidentified.
引用
收藏
页码:551 / 558
页数:8
相关论文
共 50 条
  • [1] BIOASSAY OF PROCOAGULANT ALBUMIN IN HUMAN PLASMA
    GROSSET, A
    LIU, L
    PARKER, CJ
    RODGERS, GM
    CLINICAL RESEARCH, 1994, 42 (01): : A78 - A78
  • [2] Properties of cancer procoagulant in comparison to recombinant albumin and procoagulant albumin
    Korte, W
    Knauff, T
    Gordon, S
    BLOOD, 1996, 88 (10) : 2997 - 2997
  • [3] BIOASSAY OF HUMAN PLASMA CALCITONIN
    MAZZUOLI, GF
    SCARDA, A
    ANTONOZZI, I
    COEN, G
    HORMONE RESEARCH, 1973, 4 (03) : 190 - 196
  • [4] Biochemical characterization of procoagulant albumin
    Liu, LH
    Murray, DK
    Dameron, CT
    Parker, CJ
    Rodgers, GM
    THROMBOSIS RESEARCH, 1997, 85 (05) : 399 - 411
  • [5] CHARACTERIZATION OF THE INTERACTIONS BETWEEN PROCOAGULANT ALBUMIN AND HUMAN ENDOTHELIAL-CELLS
    FAUCETTE, KJ
    FITZGERALD, LA
    LIU, LH
    PARKER, CJ
    RODGERS, GM
    BLOOD, 1993, 82 (09) : 2684 - 2692
  • [6] HUMAN PROLACTIN - EVIDENCE OBTAINED BY BIOASSAY OF HUMAN PLASMA
    FORSYTH, IA
    MYRES, RP
    JOURNAL OF ENDOCRINOLOGY, 1971, 51 (01) : 157 - +
  • [7] Human albumin or fresh plasma
    Humpe, A
    Hiddemann, W
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 1997, 122 (51-52) : 1609 - 1609
  • [8] STRUCTURE OF HUMAN PLASMA ALBUMIN
    FRANGLEN, G
    CLINICAL SCIENCE, 1970, 39 (01) : P1 - &
  • [9] BIOASSAY FOR ARA-A HUMAN-PLASMA
    BRYSON, YJ
    SWEETMAN, L
    CONNOR, JD
    PEDIATRIC RESEARCH, 1976, 10 (04) : 396 - 396
  • [10] Characterization of the phospholipid composition of procoagulant albumin
    Kling, SJ
    Rachlin, EM
    Thekkedath, UR
    Rodgers, GM
    THROMBOSIS AND HAEMOSTASIS, 1999, : 728 - 729